Table of Content

1 Penicillin Intermediate Market Overview
1.1 Product Overview and Scope of Penicillin Intermediate
1.2 Penicillin Intermediate Segment by Type
1.2.1 Global Penicillin Intermediate Market Value Comparison by Type (2024-2034)
1.2.2 6-APA
1.2.3 Penicillin G and V Potassium Salt
1.2.4 Others
1.3 Penicillin Intermediate Segment by Application
1.3.1 Global Penicillin Intermediate Market Value by Application: (2024-2034)
1.3.2 Penicillin Antibiotics
1.3.3 Cephalosporin Antibiotics
1.4 Global Penicillin Intermediate Market Size Estimates and Forecasts
1.4.1 Global Penicillin Intermediate Revenue 2024-2034
1.4.2 Global Penicillin Intermediate Sales 2024-2034
1.4.3 Global Penicillin Intermediate Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Penicillin Intermediate Market Competition by Manufacturers
2.1 Global Penicillin Intermediate Sales Market Share by Manufacturers (2024-2024)
2.2 Global Penicillin Intermediate Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Penicillin Intermediate Average Price by Manufacturers (2024-2024)
2.4 Global Penicillin Intermediate Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Penicillin Intermediate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Penicillin Intermediate, Product Type & Application
2.7 Penicillin Intermediate Market Competitive Situation and Trends
2.7.1 Penicillin Intermediate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Penicillin Intermediate Players Market Share by Revenue
2.7.3 Global Penicillin Intermediate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Penicillin Intermediate Retrospective Market Scenario by Region
3.1 Global Penicillin Intermediate Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Penicillin Intermediate Global Penicillin Intermediate Sales by Region: 2024-2034
3.2.1 Global Penicillin Intermediate Sales by Region: 2024-2024
3.2.2 Global Penicillin Intermediate Sales by Region: 2024-2034
3.3 Global Penicillin Intermediate Global Penicillin Intermediate Revenue by Region: 2024-2034
3.3.1 Global Penicillin Intermediate Revenue by Region: 2024-2024
3.3.2 Global Penicillin Intermediate Revenue by Region: 2024-2034
3.4 North America Penicillin Intermediate Market Facts & Figures by Country
3.4.1 North America Penicillin Intermediate Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Penicillin Intermediate Sales by Country (2024-2034)
3.4.3 North America Penicillin Intermediate Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Penicillin Intermediate Market Facts & Figures by Country
3.5.1 Europe Penicillin Intermediate Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Penicillin Intermediate Sales by Country (2024-2034)
3.5.3 Europe Penicillin Intermediate Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Penicillin Intermediate Market Facts & Figures by Country
3.6.1 Asia Pacific Penicillin Intermediate Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Penicillin Intermediate Sales by Country (2024-2034)
3.6.3 Asia Pacific Penicillin Intermediate Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Penicillin Intermediate Market Facts & Figures by Country
3.7.1 Latin America Penicillin Intermediate Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Penicillin Intermediate Sales by Country (2024-2034)
3.7.3 Latin America Penicillin Intermediate Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Penicillin Intermediate Market Facts & Figures by Country
3.8.1 Middle East and Africa Penicillin Intermediate Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Penicillin Intermediate Sales by Country (2024-2034)
3.8.3 Middle East and Africa Penicillin Intermediate Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Penicillin Intermediate Sales by Type (2024-2034)
4.1.1 Global Penicillin Intermediate Sales by Type (2024-2024)
4.1.2 Global Penicillin Intermediate Sales by Type (2024-2034)
4.1.3 Global Penicillin Intermediate Sales Market Share by Type (2024-2034)
4.2 Global Penicillin Intermediate Revenue by Type (2024-2034)
4.2.1 Global Penicillin Intermediate Revenue by Type (2024-2024)
4.2.2 Global Penicillin Intermediate Revenue by Type (2024-2034)
4.2.3 Global Penicillin Intermediate Revenue Market Share by Type (2024-2034)
4.3 Global Penicillin Intermediate Price by Type (2024-2034)
5 Segment by Application
5.1 Global Penicillin Intermediate Sales by Application (2024-2034)
5.1.1 Global Penicillin Intermediate Sales by Application (2024-2024)
5.1.2 Global Penicillin Intermediate Sales by Application (2024-2034)
5.1.3 Global Penicillin Intermediate Sales Market Share by Application (2024-2034)
5.2 Global Penicillin Intermediate Revenue by Application (2024-2034)
5.2.1 Global Penicillin Intermediate Revenue by Application (2024-2024)
5.2.2 Global Penicillin Intermediate Revenue by Application (2024-2034)
5.2.3 Global Penicillin Intermediate Revenue Market Share by Application (2024-2034)
5.3 Global Penicillin Intermediate Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Yili Chuanning Biotechnology
6.1.1 Yili Chuanning Biotechnology Corporation Information
6.1.2 Yili Chuanning Biotechnology Description and Business Overview
6.1.3 Yili Chuanning Biotechnology Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Yili Chuanning Biotechnology Penicillin Intermediate Product Portfolio
6.1.5 Yili Chuanning Biotechnology Recent Developments/Updates
6.2 Centrient Pharmaceuticals
6.2.1 Centrient Pharmaceuticals Corporation Information
6.2.2 Centrient Pharmaceuticals Description and Business Overview
6.2.3 Centrient Pharmaceuticals Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Centrient Pharmaceuticals Penicillin Intermediate Product Portfolio
6.2.5 Centrient Pharmaceuticals Recent Developments/Updates
6.3 Jiangxi Fushine Pharmaceutical
6.3.1 Jiangxi Fushine Pharmaceutical Corporation Information
6.3.2 Jiangxi Fushine Pharmaceutical Description and Business Overview
6.3.3 Jiangxi Fushine Pharmaceutical Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Jiangxi Fushine Pharmaceutical Penicillin Intermediate Product Portfolio
6.3.5 Jiangxi Fushine Pharmaceutical Recent Developments/Updates
6.4 Sichuan Kelun Pharmaceutical
6.4.1 Sichuan Kelun Pharmaceutical Corporation Information
6.4.2 Sichuan Kelun Pharmaceutical Description and Business Overview
6.4.3 Sichuan Kelun Pharmaceutical Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Sichuan Kelun Pharmaceutical Penicillin Intermediate Product Portfolio
6.4.5 Sichuan Kelun Pharmaceutical Recent Developments/Updates
6.5 Apeloa Pharmaceutical
6.5.1 Apeloa Pharmaceutical Corporation Information
6.5.2 Apeloa Pharmaceutical Description and Business Overview
6.5.3 Apeloa Pharmaceutical Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Apeloa Pharmaceutical Penicillin Intermediate Product Portfolio
6.5.5 Apeloa Pharmaceutical Recent Developments/Updates
6.6 North China Pharmaceutical Company
6.6.1 North China Pharmaceutical Company Corporation Information
6.6.2 North China Pharmaceutical Company Description and Business Overview
6.6.3 North China Pharmaceutical Company Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.6.4 North China Pharmaceutical Company Penicillin Intermediate Product Portfolio
6.6.5 North China Pharmaceutical Company Recent Developments/Updates
6.7 Kasugamycin hydrochloride
6.6.1 Kasugamycin hydrochloride Corporation Information
6.6.2 Kasugamycin hydrochloride Description and Business Overview
6.6.3 Kasugamycin hydrochloride Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Kasugamycin hydrochloride Penicillin Intermediate Product Portfolio
6.7.5 Kasugamycin hydrochloride Recent Developments/Updates
6.8 Sinopharm Weiqida Pharmaceutical
6.8.1 Sinopharm Weiqida Pharmaceutical Corporation Information
6.8.2 Sinopharm Weiqida Pharmaceutical Description and Business Overview
6.8.3 Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Product Portfolio
6.8.5 Sinopharm Weiqida Pharmaceutical Recent Developments/Updates
6.9 The United Laboratories International Holdings Limited
6.9.1 The United Laboratories International Holdings Limited Corporation Information
6.9.2 The United Laboratories International Holdings Limited Description and Business Overview
6.9.3 The United Laboratories International Holdings Limited Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.9.4 The United Laboratories International Holdings Limited Penicillin Intermediate Product Portfolio
6.9.5 The United Laboratories International Holdings Limited Recent Developments/Updates
6.10 Fuan Pharmaceutical group
6.10.1 Fuan Pharmaceutical group Corporation Information
6.10.2 Fuan Pharmaceutical group Description and Business Overview
6.10.3 Fuan Pharmaceutical group Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Fuan Pharmaceutical group Penicillin Intermediate Product Portfolio
6.10.5 Fuan Pharmaceutical group Recent Developments/Updates
6.11 Shanghai Shyndec Pharmaceutical
6.11.1 Shanghai Shyndec Pharmaceutical Corporation Information
6.11.2 Shanghai Shyndec Pharmaceutical Penicillin Intermediate Description and Business Overview
6.11.3 Shanghai Shyndec Pharmaceutical Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Shanghai Shyndec Pharmaceutical Penicillin Intermediate Product Portfolio
6.11.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates
6.12 Kelun
6.12.1 Kelun Corporation Information
6.12.2 Kelun Penicillin Intermediate Description and Business Overview
6.12.3 Kelun Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Kelun Penicillin Intermediate Product Portfolio
6.12.5 Kelun Recent Developments/Updates
6.13 XINXIANG BEST PHARMACEUTICAL
6.13.1 XINXIANG BEST PHARMACEUTICAL Corporation Information
6.13.2 XINXIANG BEST PHARMACEUTICAL Penicillin Intermediate Description and Business Overview
6.13.3 XINXIANG BEST PHARMACEUTICAL Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.13.4 XINXIANG BEST PHARMACEUTICAL Penicillin Intermediate Product Portfolio
6.13.5 XINXIANG BEST PHARMACEUTICAL Recent Developments/Updates
6.14 E-Cspc
6.14.1 E-Cspc Corporation Information
6.14.2 E-Cspc Penicillin Intermediate Description and Business Overview
6.14.3 E-Cspc Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.14.4 E-Cspc Penicillin Intermediate Product Portfolio
6.14.5 E-Cspc Recent Developments/Updates
6.15 Huayao Group
6.15.1 Huayao Group Corporation Information
6.15.2 Huayao Group Penicillin Intermediate Description and Business Overview
6.15.3 Huayao Group Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.15.4 Huayao Group Penicillin Intermediate Product Portfolio
6.15.5 Huayao Group Recent Developments/Updates
6.16 Hayao
6.16.1 Hayao Corporation Information
6.16.2 Hayao Penicillin Intermediate Description and Business Overview
6.16.3 Hayao Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.16.4 Hayao Penicillin Intermediate Product Portfolio
6.16.5 Hayao Recent Developments/Updates
6.17 TUL
6.17.1 TUL Corporation Information
6.17.2 TUL Penicillin Intermediate Description and Business Overview
6.17.3 TUL Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.17.4 TUL Penicillin Intermediate Product Portfolio
6.17.5 TUL Recent Developments/Updates
6.18 Henan Huaxing
6.18.1 Henan Huaxing Corporation Information
6.18.2 Henan Huaxing Penicillin Intermediate Description and Business Overview
6.18.3 Henan Huaxing Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.18.4 Henan Huaxing Penicillin Intermediate Product Portfolio
6.18.5 Henan Huaxing Recent Developments/Updates
6.19 Shanghai Hongsheng
6.19.1 Shanghai Hongsheng Corporation Information
6.19.2 Shanghai Hongsheng Penicillin Intermediate Description and Business Overview
6.19.3 Shanghai Hongsheng Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.19.4 Shanghai Hongsheng Penicillin Intermediate Product Portfolio
6.19.5 Shanghai Hongsheng Recent Developments/Updates
6.20 Sichuan Huaxin
6.20.1 Sichuan Huaxin Corporation Information
6.20.2 Sichuan Huaxin Penicillin Intermediate Description and Business Overview
6.20.3 Sichuan Huaxin Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.20.4 Sichuan Huaxin Penicillin Intermediate Product Portfolio
6.20.5 Sichuan Huaxin Recent Developments/Updates
6.21 Harbin Pharmaceutical Group
6.21.1 Harbin Pharmaceutical Group Corporation Information
6.21.2 Harbin Pharmaceutical Group Penicillin Intermediate Description and Business Overview
6.21.3 Harbin Pharmaceutical Group Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.21.4 Harbin Pharmaceutical Group Penicillin Intermediate Product Portfolio
6.21.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.22 Changzhou RedSun
6.22.1 Changzhou RedSun Corporation Information
6.22.2 Changzhou RedSun Penicillin Intermediate Description and Business Overview
6.22.3 Changzhou RedSun Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.22.4 Changzhou RedSun Penicillin Intermediate Product Portfolio
6.22.5 Changzhou RedSun Recent Developments/Updates
6.23 Jiangxi Huabang
6.23.1 Jiangxi Huabang Corporation Information
6.23.2 Jiangxi Huabang Penicillin Intermediate Description and Business Overview
6.23.3 Jiangxi Huabang Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.23.4 Jiangxi Huabang Penicillin Intermediate Product Portfolio
6.23.5 Jiangxi Huabang Recent Developments/Updates
6.24 LKPC
6.24.1 LKPC Corporation Information
6.24.2 LKPC Penicillin Intermediate Description and Business Overview
6.24.3 LKPC Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.24.4 LKPC Penicillin Intermediate Product Portfolio
6.24.5 LKPC Recent Developments/Updates
6.25 Qilu Tianhe Pharma
6.25.1 Qilu Tianhe Pharma Corporation Information
6.25.2 Qilu Tianhe Pharma Penicillin Intermediate Description and Business Overview
6.25.3 Qilu Tianhe Pharma Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.25.4 Qilu Tianhe Pharma Penicillin Intermediate Product Portfolio
6.25.5 Qilu Tianhe Pharma Recent Developments/Updates
6.26 Novartis Sandoz Anti-Infectives
6.26.1 Novartis Sandoz Anti-Infectives Corporation Information
6.26.2 Novartis Sandoz Anti-Infectives Penicillin Intermediate Description and Business Overview
6.26.3 Novartis Sandoz Anti-Infectives Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.26.4 Novartis Sandoz Anti-Infectives Penicillin Intermediate Product Portfolio
6.26.5 Novartis Sandoz Anti-Infectives Recent Developments/Updates
6.27 CSPC Zhongrun
6.27.1 CSPC Zhongrun Corporation Information
6.27.2 CSPC Zhongrun Penicillin Intermediate Description and Business Overview
6.27.3 CSPC Zhongrun Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.27.4 CSPC Zhongrun Penicillin Intermediate Product Portfolio
6.27.5 CSPC Zhongrun Recent Developments/Updates
6.28 United Laboratories
6.28.1 United Laboratories Corporation Information
6.28.2 United Laboratories Penicillin Intermediate Description and Business Overview
6.28.3 United Laboratories Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.28.4 United Laboratories Penicillin Intermediate Product Portfolio
6.28.5 United Laboratories Recent Developments/Updates
6.29 Sinopharm Weiqida Pharmaceutical
6.29.1 Sinopharm Weiqida Pharmaceutical Corporation Information
6.29.2 Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Description and Business Overview
6.29.3 Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Sales, Revenue and Gross Margin (2024-2024)
6.29.4 Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Product Portfolio
6.29.5 Sinopharm Weiqida Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Penicillin Intermediate Industry Chain Analysis
7.2 Penicillin Intermediate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Penicillin Intermediate Production Mode & Process
7.4 Penicillin Intermediate Sales and Marketing
7.4.1 Penicillin Intermediate Sales Channels
7.4.2 Penicillin Intermediate Distributors
7.5 Penicillin Intermediate Customers
8 Penicillin Intermediate Market Dynamics
8.1 Penicillin Intermediate Industry Trends
8.2 Penicillin Intermediate Market Drivers
8.3 Penicillin Intermediate Market Challenges
8.4 Penicillin Intermediate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Penicillin Intermediate Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Penicillin Intermediate Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Penicillin Intermediate Market Competitive Situation by Manufacturers in 2022
Table 4. Global Penicillin Intermediate Sales (Tons) of Key Manufacturers (2024-2024)
Table 5. Global Penicillin Intermediate Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Penicillin Intermediate Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Penicillin Intermediate Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Penicillin Intermediate Average Price (US$/Kg) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Penicillin Intermediate, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Penicillin Intermediate, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Penicillin Intermediate, Product Type & Application
Table 12. Global Key Manufacturers of Penicillin Intermediate, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Penicillin Intermediate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Penicillin Intermediate as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Penicillin Intermediate Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Penicillin Intermediate Sales by Region (2024-2024) & (Tons)
Table 18. Global Penicillin Intermediate Sales Market Share by Region (2024-2024)
Table 19. Global Penicillin Intermediate Sales by Region (2024-2034) & (Tons)
Table 20. Global Penicillin Intermediate Sales Market Share by Region (2024-2034)
Table 21. Global Penicillin Intermediate Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Penicillin Intermediate Revenue Market Share by Region (2024-2024)
Table 23. Global Penicillin Intermediate Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Penicillin Intermediate Revenue Market Share by Region (2024-2034)
Table 25. North America Penicillin Intermediate Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Penicillin Intermediate Sales by Country (2024-2024) & (Tons)
Table 27. North America Penicillin Intermediate Sales by Country (2024-2034) & (Tons)
Table 28. North America Penicillin Intermediate Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Penicillin Intermediate Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Penicillin Intermediate Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Penicillin Intermediate Sales by Country (2024-2024) & (Tons)
Table 32. Europe Penicillin Intermediate Sales by Country (2024-2034) & (Tons)
Table 33. Europe Penicillin Intermediate Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Penicillin Intermediate Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Penicillin Intermediate Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Penicillin Intermediate Sales by Region (2024-2024) & (Tons)
Table 37. Asia Pacific Penicillin Intermediate Sales by Region (2024-2034) & (Tons)
Table 38. Asia Pacific Penicillin Intermediate Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Penicillin Intermediate Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Penicillin Intermediate Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Penicillin Intermediate Sales by Country (2024-2024) & (Tons)
Table 42. Latin America Penicillin Intermediate Sales by Country (2024-2034) & (Tons)
Table 43. Latin America Penicillin Intermediate Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Penicillin Intermediate Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Penicillin Intermediate Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Penicillin Intermediate Sales by Country (2024-2024) & (Tons)
Table 47. Middle East & Africa Penicillin Intermediate Sales by Country (2024-2034) & (Tons)
Table 48. Middle East & Africa Penicillin Intermediate Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Penicillin Intermediate Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Penicillin Intermediate Sales (Tons) by Type (2024-2024)
Table 51. Global Penicillin Intermediate Sales (Tons) by Type (2024-2034)
Table 52. Global Penicillin Intermediate Sales Market Share by Type (2024-2024)
Table 53. Global Penicillin Intermediate Sales Market Share by Type (2024-2034)
Table 54. Global Penicillin Intermediate Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Penicillin Intermediate Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Penicillin Intermediate Revenue Market Share by Type (2024-2024)
Table 57. Global Penicillin Intermediate Revenue Market Share by Type (2024-2034)
Table 58. Global Penicillin Intermediate Price (US$/Kg) by Type (2024-2024)
Table 59. Global Penicillin Intermediate Price (US$/Kg) by Type (2024-2034)
Table 60. Global Penicillin Intermediate Sales (Tons) by Application (2024-2024)
Table 61. Global Penicillin Intermediate Sales (Tons) by Application (2024-2034)
Table 62. Global Penicillin Intermediate Sales Market Share by Application (2024-2024)
Table 63. Global Penicillin Intermediate Sales Market Share by Application (2024-2034)
Table 64. Global Penicillin Intermediate Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Penicillin Intermediate Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Penicillin Intermediate Revenue Market Share by Application (2024-2024)
Table 67. Global Penicillin Intermediate Revenue Market Share by Application (2024-2034)
Table 68. Global Penicillin Intermediate Price (US$/Kg) by Application (2024-2024)
Table 69. Global Penicillin Intermediate Price (US$/Kg) by Application (2024-2034)
Table 70. Yili Chuanning Biotechnology Corporation Information
Table 71. Yili Chuanning Biotechnology Description and Business Overview
Table 72. Yili Chuanning Biotechnology Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 73. Yili Chuanning Biotechnology Penicillin Intermediate Product
Table 74. Yili Chuanning Biotechnology Recent Developments/Updates
Table 75. Centrient Pharmaceuticals Corporation Information
Table 76. Centrient Pharmaceuticals Description and Business Overview
Table 77. Centrient Pharmaceuticals Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 78. Centrient Pharmaceuticals Penicillin Intermediate Product
Table 79. Centrient Pharmaceuticals Recent Developments/Updates
Table 80. Jiangxi Fushine Pharmaceutical Corporation Information
Table 81. Jiangxi Fushine Pharmaceutical Description and Business Overview
Table 82. Jiangxi Fushine Pharmaceutical Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 83. Jiangxi Fushine Pharmaceutical Penicillin Intermediate Product
Table 84. Jiangxi Fushine Pharmaceutical Recent Developments/Updates
Table 85. Sichuan Kelun Pharmaceutical Corporation Information
Table 86. Sichuan Kelun Pharmaceutical Description and Business Overview
Table 87. Sichuan Kelun Pharmaceutical Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 88. Sichuan Kelun Pharmaceutical Penicillin Intermediate Product
Table 89. Sichuan Kelun Pharmaceutical Recent Developments/Updates
Table 90. Apeloa Pharmaceutical Corporation Information
Table 91. Apeloa Pharmaceutical Description and Business Overview
Table 92. Apeloa Pharmaceutical Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 93. Apeloa Pharmaceutical Penicillin Intermediate Product
Table 94. Apeloa Pharmaceutical Recent Developments/Updates
Table 95. North China Pharmaceutical Company Corporation Information
Table 96. North China Pharmaceutical Company Description and Business Overview
Table 97. North China Pharmaceutical Company Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 98. North China Pharmaceutical Company Penicillin Intermediate Product
Table 99. North China Pharmaceutical Company Recent Developments/Updates
Table 100. Kasugamycin hydrochloride Corporation Information
Table 101. Kasugamycin hydrochloride Description and Business Overview
Table 102. Kasugamycin hydrochloride Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 103. Kasugamycin hydrochloride Penicillin Intermediate Product
Table 104. Kasugamycin hydrochloride Recent Developments/Updates
Table 105. Sinopharm Weiqida Pharmaceutical Corporation Information
Table 106. Sinopharm Weiqida Pharmaceutical Description and Business Overview
Table 107. Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 108. Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Product
Table 109. Sinopharm Weiqida Pharmaceutical Recent Developments/Updates
Table 110. The United Laboratories International Holdings Limited Corporation Information
Table 111. The United Laboratories International Holdings Limited Description and Business Overview
Table 112. The United Laboratories International Holdings Limited Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 113. The United Laboratories International Holdings Limited Penicillin Intermediate Product
Table 114. The United Laboratories International Holdings Limited Recent Developments/Updates
Table 115. Fuan Pharmaceutical group Corporation Information
Table 116. Fuan Pharmaceutical group Description and Business Overview
Table 117. Fuan Pharmaceutical group Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 118. Fuan Pharmaceutical group Penicillin Intermediate Product
Table 119. Fuan Pharmaceutical group Recent Developments/Updates
Table 120. Shanghai Shyndec Pharmaceutical Corporation Information
Table 121. Shanghai Shyndec Pharmaceutical Description and Business Overview
Table 122. Shanghai Shyndec Pharmaceutical Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 123. Shanghai Shyndec Pharmaceutical Penicillin Intermediate Product
Table 124. Shanghai Shyndec Pharmaceutical Recent Developments/Updates
Table 125. Kelun Corporation Information
Table 126. Kelun Description and Business Overview
Table 127. Kelun Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 128. Kelun Penicillin Intermediate Product
Table 129. Kelun Recent Developments/Updates
Table 130. XINXIANG BEST PHARMACEUTICAL Corporation Information
Table 131. XINXIANG BEST PHARMACEUTICAL Description and Business Overview
Table 132. XINXIANG BEST PHARMACEUTICAL Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 133. XINXIANG BEST PHARMACEUTICAL Penicillin Intermediate Product
Table 134. XINXIANG BEST PHARMACEUTICAL Recent Developments/Updates
Table 135. E-Cspc Corporation Information
Table 136. E-Cspc Description and Business Overview
Table 137. E-Cspc Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 138. E-Cspc Penicillin Intermediate Product
Table 139. E-Cspc Recent Developments/Updates
Table 140. Huayao Group Corporation Information
Table 141. Huayao Group Description and Business Overview
Table 142. Huayao Group Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 143. Huayao Group Penicillin Intermediate Product
Table 144. Huayao Group Recent Developments/Updates
Table 145. Hayao Corporation Information
Table 146. Hayao Description and Business Overview
Table 147. Hayao Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 148. Hayao Penicillin Intermediate Product
Table 149. Hayao Recent Developments/Updates
Table 150. TUL Corporation Information
Table 151. TUL Description and Business Overview
Table 152. TUL Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 153. TUL Penicillin Intermediate Product
Table 154. TUL Recent Developments/Updates
Table 155. Henan Huaxing Corporation Information
Table 156. Henan Huaxing Description and Business Overview
Table 157. Henan Huaxing Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 158. Henan Huaxing Penicillin Intermediate Product
Table 159. Henan Huaxing Recent Developments/Updates
Table 160. Shanghai Hongsheng Corporation Information
Table 161. Shanghai Hongsheng Description and Business Overview
Table 162. Shanghai Hongsheng Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 163. Shanghai Hongsheng Penicillin Intermediate Product
Table 164. Shanghai Hongsheng Recent Developments/Updates
Table 165. Sichuan Huaxin Corporation Information
Table 166. Sichuan Huaxin Description and Business Overview
Table 167. Sichuan Huaxin Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 168. Sichuan Huaxin Penicillin Intermediate Product
Table 169. Sichuan Huaxin Recent Developments/Updates
Table 170. Harbin Pharmaceutical Group Corporation Information
Table 171. Harbin Pharmaceutical Group Description and Business Overview
Table 172. Harbin Pharmaceutical Group Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 173. Harbin Pharmaceutical Group Penicillin Intermediate Product
Table 174. Harbin Pharmaceutical Group Recent Developments/Updates
Table 175. Changzhou RedSun Corporation Information
Table 176. Changzhou RedSun Description and Business Overview
Table 177. Changzhou RedSun Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 178. Changzhou RedSun Penicillin Intermediate Product
Table 179. Changzhou RedSun Recent Developments/Updates
Table 180. Jiangxi Huabang Corporation Information
Table 181. Jiangxi Huabang Description and Business Overview
Table 182. Jiangxi Huabang Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 183. Jiangxi Huabang Penicillin Intermediate Product
Table 184. Jiangxi Huabang Recent Developments/Updates
Table 185. LKPC Corporation Information
Table 186. LKPC Description and Business Overview
Table 187. LKPC Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 188. LKPC Penicillin Intermediate Product
Table 189. LKPC Recent Developments/Updates
Table 190. Qilu Tianhe Pharma Corporation Information
Table 191. Qilu Tianhe Pharma Description and Business Overview
Table 192. Qilu Tianhe Pharma Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 193. Qilu Tianhe Pharma Penicillin Intermediate Product
Table 194. Qilu Tianhe Pharma Recent Developments/Updates
Table 195. Novartis Sandoz Anti-Infectives Corporation Information
Table 196. Novartis Sandoz Anti-Infectives Description and Business Overview
Table 197. Novartis Sandoz Anti-Infectives Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 198. Novartis Sandoz Anti-Infectives Penicillin Intermediate Product
Table 199. Novartis Sandoz Anti-Infectives Recent Developments/Updates
Table 200. CSPC Zhongrun Corporation Information
Table 201. CSPC Zhongrun Description and Business Overview
Table 202. CSPC Zhongrun Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 203. CSPC Zhongrun Penicillin Intermediate Product
Table 204. CSPC Zhongrun Recent Developments/Updates
Table 205. United Laboratories Corporation Information
Table 206. United Laboratories Description and Business Overview
Table 207. United Laboratories Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 208. United Laboratories Penicillin Intermediate Product
Table 209. United Laboratories Recent Developments/Updates
Table 210. Sinopharm Weiqida Pharmaceutical Corporation Information
Table 211. Sinopharm Weiqida Pharmaceutical Description and Business Overview
Table 212. Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 213. Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Product
Table 214. Sinopharm Weiqida Pharmaceutical Recent Developments/Updates
Table 215. Key Raw Materials Lists
Table 216. Raw Materials Key Suppliers Lists
Table 217. Penicillin Intermediate Distributors List
Table 218. Penicillin Intermediate Customers List
Table 219. Penicillin Intermediate Market Trends
Table 220. Penicillin Intermediate Market Drivers
Table 221. Penicillin Intermediate Market Challenges
Table 222. Penicillin Intermediate Market Restraints
Table 223. Research Programs/Design for This Report
Table 224. Key Data Information from Secondary Sources
Table 225. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Penicillin Intermediate
Figure 2. Global Penicillin Intermediate Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Penicillin Intermediate Market Share by Type in 2022 & 2034
Figure 4. 6-APA Product Picture
Figure 5. Penicillin G and V Potassium Salt Product Picture
Figure 6. Others Product Picture
Figure 7. Global Penicillin Intermediate Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Penicillin Intermediate Market Share by Application in 2022 & 2034
Figure 9. Penicillin Antibiotics
Figure 10. Cephalosporin Antibiotics
Figure 11. Global Penicillin Intermediate Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 12. Global Penicillin Intermediate Market Size (2024-2034) & (US$ Million)
Figure 13. Global Penicillin Intermediate Sales (2024-2034) & (Tons)
Figure 14. Global Penicillin Intermediate Average Price (US$/Kg) & (2024-2034)
Figure 15. Penicillin Intermediate Report Years Considered
Figure 16. Penicillin Intermediate Sales Share by Manufacturers in 2022
Figure 17. Global Penicillin Intermediate Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Penicillin Intermediate Players: Market Share by Revenue in 2022
Figure 19. Penicillin Intermediate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 20. Global Penicillin Intermediate Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 21. North America Penicillin Intermediate Sales Market Share by Country (2024-2034)
Figure 22. North America Penicillin Intermediate Revenue Market Share by Country (2024-2034)
Figure 23. United States Penicillin Intermediate Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 24. Canada Penicillin Intermediate Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 25. Europe Penicillin Intermediate Sales Market Share by Country (2024-2034)
Figure 26. Europe Penicillin Intermediate Revenue Market Share by Country (2024-2034)
Figure 27. Germany Penicillin Intermediate Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. France Penicillin Intermediate Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. U.K. Penicillin Intermediate Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. Italy Penicillin Intermediate Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Russia Penicillin Intermediate Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Asia Pacific Penicillin Intermediate Sales Market Share by Region (2024-2034)
Figure 33. Asia Pacific Penicillin Intermediate Revenue Market Share by Region (2024-2034)
Figure 34. China Penicillin Intermediate Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Japan Penicillin Intermediate Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. South Korea Penicillin Intermediate Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. India Penicillin Intermediate Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. Australia Penicillin Intermediate Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. China Taiwan Penicillin Intermediate Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Southeast Asia Penicillin Intermediate Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Latin America Penicillin Intermediate Sales Market Share by Country (2024-2034)
Figure 42. Latin America Penicillin Intermediate Revenue Market Share by Country (2024-2034)
Figure 43. Mexico Penicillin Intermediate Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Brazil Penicillin Intermediate Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Argentina Penicillin Intermediate Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Middle East & Africa Penicillin Intermediate Sales Market Share by Country (2024-2034)
Figure 47. Middle East & Africa Penicillin Intermediate Revenue Market Share by Country (2024-2034)
Figure 48. Turkey Penicillin Intermediate Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Saudi Arabia Penicillin Intermediate Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. UAE Penicillin Intermediate Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. Global Sales Market Share of Penicillin Intermediate by Type (2024-2034)
Figure 52. Global Revenue Market Share of Penicillin Intermediate by Type (2024-2034)
Figure 53. Global Penicillin Intermediate Price (US$/Kg) by Type (2024-2034)
Figure 54. Global Sales Market Share of Penicillin Intermediate by Application (2024-2034)
Figure 55. Global Revenue Market Share of Penicillin Intermediate by Application (2024-2034)
Figure 56. Global Penicillin Intermediate Price (US$/Kg) by Application (2024-2034)
Figure 57. Penicillin Intermediate Value Chain
Figure 58. Penicillin Intermediate Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed